gvtcx

PHE - Corporate - Prescribed Medicines Review

Public Health England Published 3 Oct 2018 Contracts Finder

key details

Statuscomplete
Category (CPV) 75122000
Deadline2 Oct 2018
Contract start8 Oct 2018
Contract end30 Nov 2018
SME suitableYes
OCIDocds-b5fd17-36fc9051-d1d8-4ba2-9883-427f5795eb9d

Award

SupplierValueDateStatus
IQVIA World Publications Ltd £12,161 2 Oct 2018 active

description

PHE is conducting a review of the evidence on prescribed drugs that may cause dependence, and the short term discontinuation or longer term withdrawal symptoms, associated with prescribed medicines.

Additional information:

PHE is seeking an organisation with control of existing datasets that include information on the volume of prescribed medicines in the UK, and able to supply data on the volume (by unit) for each of the drugs included in the review that were:

1.issued within care homes in England; or
2.dispensed on private prescriptions from retail pharmacies.

The data would be required by country within the UK (England, Wales, Scotland, Northern Ireland) for the period March 2013 until April 2018 provided in monthly, quarterly and annual illustrations delivered as a single data extract by 30th November 2018.

Costs

The overall contract value will be a maximum of £12,200 (excluding VAT).

A detailed breakdown of costs is required, which will need to demonstrate value for money.

How to apply

Email details of the raw data you are able to provide and quote with breakdown of costs to Michael.Griffin@phe.gov.uk

Drug class (for this analysis) BNF chapter Drugs included Opioids

4.7.2Buprenorphine
Codeine*
Dextromoramide
Diamorphine
Dihydrocodeine**
Dipipanone (including with cyclizine)
Fentanyl
Hydromorphone
Meptazinol
Methadone
Morphine (including with cyclizine)
Oxycodone (including with naloxone)
Papaveretum
Pentazocine
Pentazocine
Pethidine
Tapentadol
Tramadol (including with paracetamol)
4.7.1Codeine with paracetamol = co-codamol*
Dihydrocodeine with paracetamol = co-dydramol**
Z-drugs
4.1.1Zaleplon
Zopiclone
Zolpidem

Benzodiazepines

  1. (insomnia)

Flurazepam

Loprazolam
Lormetazepam
Nitrazepam
Temazepam
4.1.2 (anxiety)

Diazepam

Chlordiazepoxide
Lorazepam
Oxazepam
Gabapentinoids
4.7.3Gabapentin
  1. Pregabalin

Antidepressants

  1. (Tricyclics)

Amitriptyline (including with perphenazine)

Amoxapine
Clomipramine
Dosulepin
Doxepin
Imipramine
Lofepramine
Maprotiline
Mianserin
Nortriptyline
Protriptyline
Trazodone
Trimipramine
4.3.2 (MAOIs)Isocarboxazid
Moclobemide
Phenelzine
Tranylcypromine
4.3.3 (SSRIs)Citalopram
Escitalopram
Fluoxetine
Fluvoxamine
Paroxetine
Sertraline
4.3.4 (Other antidepressants)

Agomelatine

Duloxetine
Flupentixol
Mirtazapine
Nefazodone
Oxitriptan
Reboxetine
Tryptophan
Venlafaxine
Vortioxetine

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
24 Sept 2018 Tender amendment (tenderAmendment) · c052945b-a4f5-4cf2-b874-94168c2f8d47-242379
3 Oct 2018 Award (award) · 50a2e18c-fd87-4245-a4eb-9896f057db77-244029

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.